Dysregulated microRNA expression in serum of non-vaccinated children with varicella

Viruses

Volumn 6, Issue 4, 2014, Pages 1823-1836

  Qi, Yuhua ^a   Zhu, Zheng ^a   Shi, Zhiyang ^a   Ge, Yiyue ^a   Zhao, Kangchen ^a   Zhou, Minghao ^a   Cui, Lunbiao ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Biomarker; Low density array; microRNA; qRT PCR; Varicella

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 132; MICRORNA 197; MICRORNA 363; MICRORNA 629; MOLECULAR MARKER; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; CHICKENPOX; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEVER; GENE EXPRESSION; GENE ONTOLOGY; HOST PATHOGEN INTERACTION; HUMAN; INFANT; LOW DENSITY ARRAY ANALYSIS; MALE; MRNA EXPRESSION ASSAY; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VARICELLA ZOSTER VIRUS; BLOOD; CHEMISTRY; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SERUM;

BIOLOGICAL MARKERS; CHICKENPOX; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; MICROARRAY ANALYSIS; MICRORNAS; PATHOLOGY, MOLECULAR; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; SERUM;

EID: 84899138853     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6041823     Document Type: Article

References (45)

1. Chan, J.Y.; Tian, L.; Kwan, Y.; Chan, W.; Leung, C. Hospitalizations for varicella in children and adolescents in a referral hospital in Hong Kong, 2004 to 2008: A time series study. BMC Public Health 2011, 11, e366.
2. Pierik, J.G.; Gumbs, P.D.; Fortanier, S.A.; van Steenwijk, P.C.; Postma, M.J. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect. Dis. 2012, 12, e110.
3. Nguyen, H.Q.; Jumaan, A.O.; Seward, J.F. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N. Engl. J. Med. 2005, 352, 450-458.
4. Xiong, X.; Qi, Y.; Jiao, J.; Gong, W.; Duan, C.; Wen, B. Exploratory study on Th1 epitope-induced protective immunity against Coxiella burnetii infection. PLoS One 2014, 9, e87206.
5. Tseng, H.F.; Tan, H.F.; Chang, C.K.; Wang, L.Y.; Yang, S.E.; Liau, M.Y.; Pan, M.J.; Chen, C.Y.; Huang, S.P. A seroepidemiology study of varicella among children aged 0-12 years in Taiwan. Southeast Asian J. Trop. Med. Public Health 2005, 36, 1201-1207.
6. Heininger, U.; Seward, J.F. Varicella. Lancet 2006, 368, 1365-1376.
7. Lu, L.; Suo, L.; Li, J.; Zhai, L.; Zheng, Q.; Pang, X.; Bialek, S.R.; Wang, C. A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China. Vaccine 2012, 30, 5094-5098.
8. Xu, A.; Xu, Q.; Fang, X.; Bialek, S.; Wang, C. Varicella vaccine uptake in Shandong Province, China. Hum. Vaccines Immunother. 2012, 8, 1213-1217.
9. Galil, K.; Brown, C.; Lin, F.; Seward, J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr. Infect. Dis. J. 2002, 21, 931-935.
10. Solomon, A.R. New diagnostic tests for herpes simplex and varicella zoster infections. J. Am. Acad. Dermatol. 1988, 18, 218-221.
11. Wilson, D.A.; Yen-Lieberman, B.; Schindler, S.; Asamoto, K.; Schold, J.D.; Procop, G.W. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J. Clin. Microbiol. 2012, 50, 4120-4122.
12. Leung, J.; Harpaz, R.; Baughman, A.L.; Heath, K.; Loparev, V.; Vazquez, M.; Watson, B.M.; Schmid, D.S. Evaluation of laboratory methods for diagnosis of varicella. Clin. Infect. Dis. 2010, 51, 23-32.
13. Weidmann, M.; Meyer-Konig, U.; Hufert, F.T. Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR. J. Clin. Microbiol. 2003, 41, 1565-1568.
14. Parker, S.P.; Quinlivan, M.; Taha, Y.; Breuer, J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J. Clin. Microbiol. 2006, 44, 3911-3914.
15. Kierat, S.; Les, K.; Przybylski, M.; Dzieciatkowski, T.; Mlynarczyk, G. TaqMan fluorescent probe-based real-time PCR assay for detection of varicella-zoster virus. Med. Dosw. Mikrobiol. 2012, 64, 139-149.
16. Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281-297.
17. Singh, S.K.; Bhadra, M.P.; Girschick, H.J.; Bhadra, U. MicroRNAs-Micro in size but macro in function. FEBS J. 2008, 275, 4929-4944.
18. Godfrey, A.C.; Xu, Z.; Weinberg, C.R.; Getts, R.C.; Wade, P.A.; Deroo, L.A.; Sandler, D.P.; Taylor, J.A. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 2013, 15, R42.
19. Hennessey, P.T.; Sanford, T.; Choudhary, A.; Mydlarz, W.W.; Brown, D.; Adai, A.T.; Ochs, M.F.; Ahrendt, S.A.; Mambo, E.; Califano, J.A. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012, 7, e32307.
20. Sun, Y.; Wang, M.; Lin, G.; Sun, S.; Li, X.; Qi, J.; Li, J. Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One 2012, 7, e47003.
21. Gu, H.; Li, H.; Zhang, L.; Luan, H.; Huang, T.; Wang, L.; Fan, Y.; Zhang, Y.; Liu, X.; Wang, W. et al. Diagnostic role of microRNA expression profile in the serum of pregnant women with fetuses with neural tube defects. J. Neurochem. 2012, 122, 641-649.
22. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107, 810-817.
23. Xu, B.; Hsu, P.K.; Stark, K.L.; Karayiorgou, M.; Gogos, J.A. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell 2013, 152, 262-275.
24. Cui, L.; Qi, Y.; Li, H.; Ge, Y.; Zhao, K.; Qi, X.; Guo, X.; Shi, Z.; Zhou, M.; Zhu, B. et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One 2011, 6, e27071.
25. Qi, Y.; Cui, L.; Ge, Y.; Shi, Z.; Zhao, K.; Guo, X.; Yang, D.; Yu, H.; Shan, Y.; Zhou, M. et al. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect. Dis. 2012, 12, e384.
26. Chen, X.; Ba, Y.; Ma, L.J.; Cai, X.; Yin, Y.; Wang, K.H.; Guo, J.G.; Zhang, Y.J.; Chen, J.N.; Guo, X. et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18, 997-1006.
27. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
28. Chen, L.; Li, C.; Peng, Z.; Zhao, J.; Gong, G.; Tan, D. miR-197 Expression in peripheral blood mononuclear cells from hepatitis B virus-infected patients. Gut Liver 2013, 7, 335-342.
29. Hamada, S.; Satoh, K.; Miura, S.; Hirota, M.; Kanno, A.; Masamune, A.; Kikuta, K.; Kume, K.; Unno, J.; Egawa, S. et al. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J. Cell. Physiol. 2013, 228, 1255-1263.
30. Grassmann, R.; Jeang, K.T. The roles of microRNAs in mammalian virus infection. Biochim. Biophys. Acta 2008, 1779, 706-711.
31. Ma, F.; Xu, S.; Liu, X.; Zhang, Q.; Xu, X.; Liu, M.; Hua, M.; Li, N.; Yao, H.; Cao, X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat. Immunol. 2011, 12, 861-869.
32. Xiao, B.; Liu, Z.; Li, B.S.; Tang, B.; Li, W.; Guo, G.; Shi, Y.; Wang, F.; Wu, Y.; Tong, W.D. et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J. Infect. Dis. 2009, 200, 916-925.
33. Koh, Y.W.; Park, C.; Yoon, D.H.; Suh, C.; Huh, J. Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma. Am. J. Surg. Pathol. 2013, 37, 1242-1251.
34. Wu, X.; Wu, S.; Tong, L.; Luan, T.; Lin, L.; Lu, S.; Zhao, W.; Ma, Q.; Liu, H.; Zhong, Z. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells. Scand. J. Gastroenterol. 2009, 44, 1332-1339.
35. Lewis, A.P.; Jopling, C.L. Regulation and biological function of the liver-specific miR-122. Biochem. Soc. Trans. 2010, 38, 1553-1557.
36. Fan, C.G.; Wang, C.M.; Tian, C.; Wang, Y.; Li, L.; Sun, W.S.; Li, R.F.; Liu, Y.G. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncol. Rep. 2011, 26, 1281-1286.
37. Yang, D.; Li, T.; Wang, Y.; Tang, Y.; Cui, H.; Zhang, X.; Chen, D.; Shen, N.; Le, W. miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J. Cell Sci. 2012, 125, 1673-1682.
38. Qiao, J.; Lee, S.; Paul, P.; Theiss, L.; Tiao, J.; Qiao, L.; Kong, A.; Chung, D.H. miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis. Surgery 2013, 154, 226-233.
39. Chokas, A.L.; Trivedi, C.M.; Lu, M.M.; Tucker, P.W.; Li, S.; Epstein, J.A.; Morrisey, E.E. Foxp1/2/4-NuRD interactions regulate gene expression and epithelial injury response in the lung via regulation of interleukin-6. J. Biol. Chem. 2010, 285, 13304-13313.
40. Shu, W.; Lu, M.M.; Zhang, Y.; Tucker, P.W.; Zhou, D.; Morrisey, E.E. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 2007, 134, 1991-2000.
41. SDS Software, version 2.3. Applied Biosystems: Foster City, CA, USA, 2006.
42. RQ Manager, version1.2.1. Applied Biosystems: Foster City, CA, USA, 2006.
43. TargetScan. Available online: http://www.targetscan.org/ (accessed on 30 June 2012).
44. DAVID server. Available online: http://david.abcc.ncifcrf.gov/tools.jsp/ (accessed on 30 June 2012).
45. SPSS software, version 16.0, SPSS Inc.: Chicago, IL, USA. 2007.